Startseite>>Signaling Pathways>> Apoptosis>> RIP kinase>>RIPK1-IN-3

RIPK1-IN-3

Katalog-Nr.GC37535

RIPK1-IN-3 (Beispiel 38), ein RIPK1-Inhibitor, extrahiert aus dem Patent WO2018148626A1, besitzt entzÜndungshemmende Eigenschaften.

Products are for research use only. Not for human use. We do not sell to patients.

RIPK1-IN-3 Chemische Struktur

Cas No.: 2242677-36-5

Größe Preis Lagerbestand Menge
100mg Please Inquire Please Inquire
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

RIPK1-IN-3 (Example 38), a RIPK1 inhibitor, extracted from patent WO2018148626A1, possesses anti-inflammatory proprieties[1].

[1]. Guo Junqing, et al. Aminotriazolopyridines as kinase inhibitors. WO/2018/148626A1.

Bewertungen

Review for RIPK1-IN-3

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for RIPK1-IN-3

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.